SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+36.17%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$311M
AUM Growth
+$311M
(+79%)
Cap. Flow
+$93.5M
Cap. Flow
% of AUM
30.09%
Top 10 Holdings %
Top 10 Hldgs %
74.66%
Holding
36
New
8
Increased
5
Reduced
10
Closed
4
Top Buys
1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$73.4M |
2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$12.8M |
3 |
Spyre Therapeutics
SYRE
|
$8.95M |
4 |
Geron
GERN
|
$8.48M |
5 |
Fulcrum Therapeutics
FULC
|
$5.38M |
Top Sells
1 |
Liquidia Corp
LQDA
|
$4.78M |
2 |
Tempest Therapeutics
TPST
|
$3.97M |
3 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$3.47M |
4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.85M |
5 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$2.46M |
Sector Composition
1 | Healthcare | 97.05% |